시장보고서

상품코드

1401003

사지마비 치료 시장 : 치료 유형별, 투여 경로별, 유통 채널별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율, 예측(2023-2030년)

Quadriplegia Treatment Market, By Treatment Type, By Route of Administration, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

발행일: 2023년 12월 | 리서치사:

AnalystView Market Insights | 페이지 정보: 영문 287 Pages | 배송안내 : 2-3일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

사지마비 치료 시장 규모는 2022년에 14억 6,840만 달러를 기록했으며, 2023-2030년 CAGR 4.3 %로 확대할 것으로 예상됩니다.

사지마비 치료제 시장 - 시장 역학

신경 보철 기술 BCI 기술의 급속한 발전으로 시장 수요를 촉진합니다.

혁명적인 방법으로 뇌와 외부 기기가 직접 접촉할 수 있게 되면서 사지마비 환자들이 팔다리의 기능과 움직임을 되찾을 수 있는 희망을 가질 수 있게 되었습니다. 그 원동력은 과학의 발전과 더 많은 자유를 원하는 환자들 수요 증가에 있습니다. 연구자, 신경과학자 및 기업은 사지마비 환자의 삶의 질을 개선하고, 신경 재활의 새로운 지평을 열고, 이전에는 상상할 수 없었던 수준의 회복을 실현하고자 하는 열망에 따라 보다 정교한 BCI 및 신경 보철물 개발에 많은 투자를 하고 있습니다.

사지마비 치료 시장 - 주요 인사이트

AnalystView Market Insights의 리서치 애널리스트들의 분석에 따르면 세계 사지마비 치료제 시장은 예측 기간(2023-2030년) 동안 약 4.3%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예상됩니다.

신경보철 및 BCI 기술의 급속한 발전으로 사지마비 치료 산업은 빠른 속도로 성장할 것으로 예상됩니다.

시장 세분화에서 코르티코스테로이드는 2022년에 가장 높은 시장 점유율을 보였습니다.

투여 경로별로는 경구투여가 2022년 주요 치료 유형으로 나타났습니다.

지역별로는 아시아태평양이 2022년 매출에서 선두를 달리고 있습니다.

사지마비 치료제 시장 - 세분화 분석 :

세계 사지마비 치료 시장은 치료 유형, 투여 경로, 유통 채널 및 지역에 따라 세분화됩니다.

시장은 치료 유형에 따라 코르티코스테로이드, 비스테로이드성 항염증제, 항우울제, 항경련제, 마약성 진통제, 진경련제, 근이완제 등 6가지로 나뉩니다. 코르티코 스테로이드가 시장을 독점하고 있습니다. 코르티코스테로이드 치료는 사지마비 치료에서 부족합니다. 코르티코스테로이드는 주로 항염증 특성으로 인해 급성 척수손상 치료에 사용되지만 그 효과는 극히 미미합니다. 물리치료, 보조기구, 신경재활 등 다른 치료법이 사지마비 환자의 기능과 삶의 질을 향상시키는 데 큰 역할을 하고 있습니다.

시장은 투여 경로에 따라 경구 투여와 정맥 투여의 두 가지 범주로 나뉩니다. 경구용이 시장을 지배하고 있으며, 예측 기간 중 경구용이 우위를 점할 것으로 예상됩니다.

사지마비 치료 시장 - 지역적 인사이트

지역적으로 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 걸쳐 있습니다. 이 지역은 비즈니스를 가져 오는 국가에 따라 더 세분화됩니다. 아시아태평양의 사지마비 치료의 필요성에 영향을 미치는 몇 가지 변수가 있습니다. 이 지역에는 사고나 다른 이유로 인해 다양한 정도의 척수 손상을 입은 인구가 많습니다. 또한 의료 인프라의 개선과 전문 재활 서비스의 가용성으로 인해 완전한 사지마비 치료에 대한 인식과 수요가 증가하고 있습니다. 또한 외골격 및 신경 보조기구와 같은 보조 기술의 발전은 이 지역 사지마비 환자들의 삶의 질을 향상시킬 수 있는 현실적인 해결책으로 각광받고 있습니다. 마지막으로, 인구의 고령화로 인해 노화와 관련된 척수 손상 및 퇴행성 장애의 영향에 대처할 수 있는 효과적인 치료법의 필요성이 높아질 수 있습니다.

서론
북미
- 개요
- 북미의 주요 제조업체
- 미국
- 캐나다
유럽
- 개요
- 유럽의 주요 제조업체
- 독일
- 이탈리아
- 영국
- 프랑스
- 러시아
- 네덜란드
- 스웨덴
- 폴란드
- 기타
아시아태평양(APAC)
- 개요
- 아시아태평양의 주요 제조업체
- 인도
- 중국
- 일본
- 한국
- 호주
- 태국
- 인도네시아
- 필리핀
- 기타
라틴아메리카
- 개요
- 라틴아메리카의 주요 제조업체
- 브라질
- 멕시코
- 아르헨티나
- 콜롬비아
- 기타
중동 및 아프리카
- 개요
- 중동 및 아프리카의 주요 제조업체
- 사우디아라비아
- 아랍에미리트
- 이스라엘
- 터키
- 알제리
- 이집트
- 기타

제11장 주요 벤더 분석 : 사지마비 치료 업계

경쟁 대시보드
기업 개요
- ReWalk Robotics
- Ekso Bionics
- Cyberdyne Inc.
- Invacare Corporation
- Hocoma AG
- Axogen Corporation
- Myomo Inc.
- Ossur
- Parker Hannifin
- InVivo Therapeutics
- University of California, Los Angeles(UCLA)
- The Miami Project to Cure Paralysis
- Kennedy Krieger Institute
- Cleveland Clinic
- Swiss Paraplegic Centre

제12장 애널리스트의 전방위 전망

KSA 24.01.09

REPORT HIGHLIGHT

Quadriplegia Treatment Market size was valued at USD 1,468.4 Million in 2022, expanding at a CAGR of 4.3 % from 2023 to 2030.

Quadriplegia therapy is a complex strategy to address the physical and functional restrictions caused by severe spinal cord injuries, which normally affect all four limbs and often end in considerable paralysis. While comprehensive treatments are presently unattainable, quadriplegia therapy focuses on improving afflicted persons' quality of life and independence. This encompasses physical therapy, assistive devices, mobility aids, and sophisticated technology including exoskeletons and neuroprosthetics. In addition, continuing research looks at regenerative medicine, brain interfaces, and other novel therapies to help quadriplegics regain function and autonomy.

Quadriplegia Treatment Market- Market Dynamics

Rapid development of neuroprosthetic and brain-computer interface (BCI) technologies propel market demand

Revolutionary methods allow direct contact between the brain and external equipment, providing hope for quadriplegics to regain limb function and movement. The driving force is a combination of scientific advancements and growing demand from patients desiring more freedom. Researchers, neuroscientists, and companies are investing heavily in the development of more sophisticated BCIs and neuroprosthetics, motivated by the desire to improve the quality of life for quadriplegics and open up new frontiers in neural rehabilitation, allowing previously unimaginable levels of restoration to become a reality.

Quadriplegia Treatment Market- Key Insights

As per the analysis shared by our research analyst, the global Quadriplegia Treatment market is estimated to grow annually at a CAGR of around 4.3% over the forecast period (2023-2030)

The Quadriplegia Treatment industry is projected to grow at a significant rate due to rapid development of neuroprosthetic and brain-computer interface (BCI) technologies

Based on Treatment Type segmentation, Corticosteroids was predicted to show maximum market share in the year 2022

Based on Route of Administration segmentation, Oral was the leading Treatment Type in 2022

On the basis of region, Asia Pacific was the leading revenue generator in 2022

Quadriplegia Treatment Market- Segmentation Analysis:

The Global Quadriplegia Treatment Market is segmented on the basis of Treatment Type, Route of Administration, Distribution Channel, and Region.

The market is divided into six categories based on Treatment Type: Corticosteroids, Non- Steroidal Anti-inflammatory Drugs, Antidepressants, Anticonvulsants, Narcotic Analgesics, Antispasmodics & Muscle Relaxants. The Corticosteroids dominates the market. Corticosteroid therapies are in short supply in quadriplegia therapy. Corticosteroids are largely utilized for their anti-inflammatory qualities in the treatment of acute spinal cord injuries, however they have demonstrated minimal efficacy. Other treatment methods, including as physical therapy, assistive devices, and neurorehabilitation procedures, play a larger role in increasing quadriplegic people' function and quality of life.

The market is divided into two categories based on Route of Administration: Oral, Intravenous. The Oral sector dominates the market and is likely to maintain its dominance during the forecast period. Oral therapies are seldom used in quadriplegia therapy because they are unsuccessful in addressing the underlying causes of this disorder, which are spinal cord injuries. Physical therapy, assistive devices, and more specialized therapies are the primary treatment focuses, with oral drugs having a minor part in quadriplegia management.

Quadriplegia Treatment Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Several variables impact the need for quadriplegia therapy in the Asia-Pacific area. The region has a sizable population with varied degrees of spinal cord injury caused by accidents and other reasons. Furthermore, growing awareness and demand for complete quadriplegia therapy have resulted from improved healthcare infrastructure and the availability of specialized rehabilitation services. Additionally, advances in assistive technology, including as exoskeletons and neuroprosthetics, are gaining traction as viable solutions to enhance the quality of life for quadriplegic people in the area. Finally, an aging population may increase the need for effective therapies to address the effects of age-related spinal cord injuries and degenerative disorders.

Quadriplegia Treatment Market- Competitive Landscape:

Healthcare providers, rehabilitation centers, assistive technology manufacturers, and research organizations make up the competitive environment in quadriplegia therapy. ReWalk Robotics and Ekso Bionics, for example, specialize in building robotic exoskeletons to improve movement. The Miami Project to Cure Paralysis and the Christopher and Dana Reeve Foundation sponsor research to develop quadriplegia therapies. Comprehensive treatment and therapy are provided by rehabilitation centers such as the Kennedy Krieger Institute. Collaboration between these players is taking place in the field to develop innovative treatments, such as neuroprosthetics and regenerative medicine, with the goal of improving independence and rehabilitation for quadriplegic individuals and expanding the range of available options in this specialized healthcare domain.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL QUADRIPLEGIA TREATMENT MARKET KEY PLAYERS

ReWalk Robotics
Ekso Bionics
Cyberdyne Inc.
Invacare Corporation
Hocoma AG
Axogen Corporation
Myomo Inc.
Ossur
Parker Hannifin
InVivo Therapeutics
University of California, Los Angeles (UCLA)
The Miami Project to Cure Paralysis
Kennedy Krieger Institute
Cleveland Clinic
Swiss Paraplegic Centre

GLOBAL QUADRIPLEGIA TREATMENT MARKET, BY TREATMENT TYPE

Corticosteroids
Non- Steroidal Anti-inflammatory Drugs
Antidepressants
Anticonvulsants
Narcotic Analgesics
Antispasmodics & Muscle Relaxants

GLOBAL QUADRIPLEGIA TREATMENT MARKET, BY ROUTE OF ADMINISTRATION

Oral
Intravenous

GLOBAL QUADRIPLEGIA TREATMENT MARKET, BY DISTRIBUTION CHANNEL

Hospital
Pharmacies
Retail Pharmacies
Drug Stores
Online Stores

GLOBAL QUADRIPLEGIA TREATMENT MARKET, BY REGION

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

1. Quadriplegia Treatment Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Quadriplegia Treatment Market Snippet by Treatment Type
- 2.1.2. Quadriplegia Treatment Market Snippet by Route of Administration
- 2.1.3. Quadriplegia Treatment Market Snippet by Distribution Channel
- 2.1.4. Quadriplegia Treatment Market Snippet by Country
- 2.1.5. Quadriplegia Treatment Market Snippet by Region
2.2. Competitive Insights

3. Quadriplegia Treatment Key Market Trends

3.1. Quadriplegia Treatment Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Quadriplegia Treatment Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Quadriplegia Treatment Market Opportunities
3.4. Quadriplegia Treatment Market Future Trends

4. Quadriplegia Treatment Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Quadriplegia Treatment Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Quadriplegia Treatment Market Landscape

6.1. Quadriplegia Treatment Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Quadriplegia Treatment Market - By Treatment Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Treatment Type, 2022 & 2030 (%)
- 7.1.2. Corticosteroids
- 7.1.3. Non- Steroidal Anti-inflammatory Drugs
- 7.1.4. Antidepressants
- 7.1.5. Anticonvulsants
- 7.1.6. Narcotic Analgesics
- 7.1.7. Antispasmodics & Muscle Relaxants

8. Quadriplegia Treatment Market - By Route of Administration

8.1. Overview
- 8.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
- 8.1.2. Oral
- 8.1.3. Intravenous

9. Quadriplegia Treatment Market - By Distribution Channel

9.1. Overview
- 9.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
- 9.1.2. Hospital
- 9.1.3. Pharmacies
- 9.1.4. Retail Pharmacies
- 9.1.5. Drug Stores
- 9.1.6. Online Stores

10. Quadriplegia Treatment Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Quadriplegia Treatment Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Quadriplegia Treatment Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Quadriplegia Treatment Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Quadriplegia Treatment Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Quadriplegia Treatment Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Treatment Type, 2018 - 2030 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Quadriplegia Treatment Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. ReWalk Robotics
- 11.2.2. Ekso Bionics
- 11.2.3. Cyberdyne Inc.
- 11.2.4. Invacare Corporation
- 11.2.5. Hocoma AG
- 11.2.6. Axogen Corporation
- 11.2.7. Myomo Inc.
- 11.2.8. Ossur
- 11.2.9. Parker Hannifin
- 11.2.10. InVivo Therapeutics
- 11.2.11. University of California, Los Angeles (UCLA)
- 11.2.12. The Miami Project to Cure Paralysis
- 11.2.13. Kennedy Krieger Institute
- 11.2.14. Cleveland Clinic
- 11.2.15. Swiss Paraplegic Centre

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us